Rafarma Pharmaceuticals (RAFA) Ratios
Rafarma Pharmaceuticals Ratios
RAFA's free cash flow for Q1 2026 was $40.00K. For the 2026 fiscal year, RAFA's free cash flow was decreased by $-1.00K and operating cash flow was $41.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.13 | 1.13 | 1.23 | 3.03 | 2.90 |
| Quick Ratio | 1.03 | 1.03 | 1.18 | 1.93 | 1.78 |
| Cash Ratio | 0.04 | 0.05 | 0.04 | 1.01 | 0.71 |
| Solvency Ratio | 0.23 | 0.16 | 0.27 | 0.25 | 0.60 |
| Operating Cash Flow Ratio | 0.08 | 0.03 | -30.64 | 1.06 | 0.15 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 52.14 | 1.78 |
| Net Current Asset Value | $ 172.00K | $ 207.00K | $ 385.00K | $ 33.54M | $ 35.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.16 | 1.16 | 1.26 | 1.29 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 14.42 | 7.26 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Net Debt to EBITDA | -0.07 | -0.23 | -0.13 | -2.66 | -0.81 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.29% | 7.42% | 5.92% | 35.47% | 35.23% |
| EBIT Margin | 5.33% | 3.77% | 3.54% | 9.68% | 18.84% |
| EBITDA Margin | 5.33% | 3.77% | 5.20% | 10.04% | 19.02% |
| Operating Profit Margin | 5.33% | 4.46% | 3.09% | 11.12% | 19.02% |
| Pretax Profit Margin | 4.65% | 3.78% | 3.55% | 9.68% | 18.84% |
| Net Profit Margin | 3.80% | 2.93% | 2.69% | 7.71% | 14.95% |
| Continuous Operations Profit Margin | 3.80% | 2.93% | 2.69% | 7.71% | 14.95% |
| Net Income Per EBT | 81.73% | 77.55% | 75.83% | 79.69% | 79.34% |
| EBT Per EBIT | 87.32% | 84.69% | 115.02% | 87.06% | 99.06% |
| Return on Assets (ROA) | 2.91% | 2.21% | 2.24% | 5.05% | 12.95% |
| Return on Equity (ROE) | 3.32% | 2.56% | 2.60% | 6.37% | 16.65% |
| Return on Capital Employed (ROCE) | 4.65% | 3.90% | 2.98% | 8.88% | 20.95% |
| Return on Invested Capital (ROIC) | 3.80% | 3.03% | 2.26% | 7.04% | 16.25% |
| Return on Tangible Assets | 2.91% | 2.21% | 2.24% | 5.05% | 12.95% |
| Earnings Yield | 14.50% | 3.70% | 1.19% | 12.88% | 15.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.35 | 5.60 | 5.39 | 4.16 | 3.81 |
| Payables Turnover | 6.06 | 5.36 | 6.08 | 2.42 | 2.91 |
| Inventory Turnover | 53.27 | 53.87 | 102.53 | 2.11 | 2.35 |
| Fixed Asset Turnover | 79.80 | 79.63 | 88.13 | 1.60 | 2.72 |
| Asset Turnover | 0.77 | 0.75 | 0.83 | 0.65 | 0.87 |
| Working Capital Turnover Ratio | 45.66 | 30.67 | 0.55 | 1.78 | 2.48 |
| Cash Conversion Cycle | 4.17 | 3.85 | 11.24 | 109.78 | 125.49 |
| Days of Sales Outstanding | 57.51 | 65.18 | 67.71 | 87.70 | 95.80 |
| Days of Inventory Outstanding | 6.85 | 6.78 | 3.56 | 173.17 | 155.07 |
| Days of Payables Outstanding | 60.20 | 68.10 | 60.02 | 151.09 | 125.38 |
| Operating Cycle | 64.36 | 71.95 | 71.27 | 260.87 | 250.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | -0.58 | 0.21 | 0.03 |
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | 0.08 | 0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.88 | 1.00 | -1.00 | 1.55 | 0.84 |
| Capital Expenditure Coverage Ratio | 0.88 | 1.00 | -1.00 | 1.55 | 0.00 |
| Operating Cash Flow Coverage Ratio | 4.87 | 0.00 | 0.00 | 20.65 | 1.69 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.00 | -5.00 | 0.29 | 0.04 |
| Free Cash Flow Yield | -0.66% | 0.61% | 0.00% | 17.37% | 3.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.86 | 27.33 | 84.01 | 7.76 | 6.33 |
| Price-to-Sales (P/S) Ratio | 0.26 | 0.79 | 2.26 | 0.60 | 0.95 |
| Price-to-Book (P/B) Ratio | 0.23 | 0.69 | 2.18 | 0.49 | 1.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -150.44 | 163.57 | 0.00 | 5.76 | 25.47 |
| Price-to-Operating Cash Flow Ratio | 21.49 | 163.57 | -0.45 | 2.05 | 25.47 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | -8.47 | -0.89 | -0.14 | -0.27 |
| Enterprise Value Multiple | 4.85 | 20.82 | 43.40 | 3.31 | 4.17 |
| Enterprise Value | 2.37M | 7.12M | 22.87M | 21.37M | 61.37M |
| EV to EBITDA | 4.85 | 20.82 | 43.40 | 3.31 | 4.17 |
| EV to Sales | 0.26 | 0.78 | 2.26 | 0.33 | 0.79 |
| EV to Free Cash Flow | -148.25 | 161.82 | 0.00 | 3.20 | 21.33 |
| EV to Operating Cash Flow | 21.18 | 161.82 | -0.45 | 1.14 | 21.33 |
| Tangible Book Value Per Share | 0.12 | 0.12 | 0.12 | 0.89 | 0.79 |
| Shareholders’ Equity Per Share | 0.12 | 0.12 | 0.12 | 0.89 | 0.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.22 | 0.24 | 0.20 | 0.21 |
| Revenue Per Share | 0.10 | 0.10 | 0.12 | 0.73 | 0.88 |
| Net Income Per Share | 0.00 | 0.00 | 0.00 | 0.06 | 0.13 |
| Tax Burden | 0.82 | 0.78 | 0.76 | 0.80 | 0.79 |
| Interest Burden | 0.87 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.32 | 0.17 | -185.61 | 3.78 | 287.70 |
Currency in USD
